Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1200/OP.20.00295 http://scihub22266oqcxt.onion/10.1200/OP.20.00295 32539650!?!32539650 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32539650&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       JCO+Oncol+Pract 2020 ; 16 (11): e1282-e1290 Nephropedia Template TP {{tp|p=32539650|t=2020. Providing Oncology Pharmacy Services During the Coronavirus Pandemic: French Society for Oncology Pharmacy (Societe Francaise de Pharmacie Oncologique SFPO ) Guidelines |pdf=|usr=}}{{32539650}} gab.com Text Providing Oncology Pharmacy Services During the Coronavirus Pandemic: French Society for Oncology Pharmacy (Societe Francaise de Pharmacie Oncologique SFPO ) Guidelines JO: JCO Oncol Pract http://www.kidney.de/pget.php?&tw=1&pmid=32539650 #FOAvip PURPOSE: Patients with cancer are at higher risk for contracting the COVID-19 infection and are more likely to have higher morbidity and mortality. This is a big challenge for oncology teams that have to treat patients to avoid contamination by SARS-CoV-2. The aim of the current work is to present oncology pharmacy practice guidelines during the COVID-19 pandemic to secure the pharmaceutical care of patients with cancer. METHODS: The bureau of the French Society for Oncology Pharmacy proposed these recommendations according to the French High Authority of Health following the Guidelines of Good Practice, slightly modified according to the pandemic crisis situation. These guidelines were developed by a working group of 7 experts in oncology pharmacy practice. Furthermore, the guidelines were assessed by 31 independent reviewers. RESULTS: One hundred percent of reviewers approved the guidelines and 90% of them suggested some improvements. The final version incorporates the best comments and consists of 26 recommendations organized in 8 different sections. CONCLUSION: These guidelines allow secure pharmaceutical management of patients with cancer during the COVID-19 pandemic. Twit Text FOAVip Providing Oncology Pharmacy Services During the Coronavirus Pandemic: French Society for Oncology Pharmacy (Societe Francaise de Pharmacie Oncologique SFPO ) Guidelines ????JCO Oncol Pract http://www.kidney.de/pget.php?&tw=1&pmid=32539650 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32539650 #FOAvip English Wikipedia <ref>{{Cite pmid|32539650}}</ref> Providing Oncology Pharmacy Services During the Coronavirus Pandemic: French Society for Oncology Pharmacy (Societe Francaise de Pharmacie Oncologique SFPO ) Guidelines #MMPMID32539650 Pourroy B; Tournamille JF; Bardin C; Slimano F; Chevrier R; Rioufol C; Madelaine I JCO Oncol Pract 2020[Nov]; 16 (11): e1282-e1290 PMID32539650show ga PURPOSE: Patients with cancer are at higher risk for contracting the COVID-19 infection and are more likely to have higher morbidity and mortality. This is a big challenge for oncology teams that have to treat patients to avoid contamination by SARS-CoV-2. The aim of the current work is to present oncology pharmacy practice guidelines during the COVID-19 pandemic to secure the pharmaceutical care of patients with cancer. METHODS: The bureau of the French Society for Oncology Pharmacy proposed these recommendations according to the French High Authority of Health following the Guidelines of Good Practice, slightly modified according to the pandemic crisis situation. These guidelines were developed by a working group of 7 experts in oncology pharmacy practice. Furthermore, the guidelines were assessed by 31 independent reviewers. RESULTS: One hundred percent of reviewers approved the guidelines and 90% of them suggested some improvements. The final version incorporates the best comments and consists of 26 recommendations organized in 8 different sections. CONCLUSION: These guidelines allow secure pharmaceutical management of patients with cancer during the COVID-19 pandemic. |*COVID-19 Drug Treatment[MESH] |*Pandemics[MESH] |COVID-19/complications/epidemiology/virology[MESH] |Female[MESH] |France/epidemiology[MESH] |Humans[MESH] |Male[MESH] |Medical Oncology/trends[MESH] |Neoplasms/complications/*drug therapy/epidemiology/virology[MESH] |Pharmaceutical Services[MESH] |Pharmacies/trends[MESH] |Practice Guidelines as Topic[MESH]Providing Oncology Pharmacy Services During the Coronavirus Pandemic: (epmc).pdf DeepDyve Pubget Overpricing